Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

205
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
205
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.3K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.3K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial Orchestration of Skin Fibrosis by a CD8+ T cell-Myofibroblast Axis.

bioRxiv : the preprint server for biology·2026
Same author

Plasma or Serum? A Pilot Evaluation of Matrix Selection for Integrated Metabolomics and Exposomics of Clinical Samples.

Toxics·2026
Same author

Letter to the Editor Regarding the Article "Ayurvedic Treatments for Hair Disorders: A Narrative Review".

Skin appendage disorders·2026
Same author

Expanding vaginal microbiome pangenomes via a custom MIDAS database reveals <i>Lactobacillus crispatus</i> accessory genes associated with cervical dysplasia.

mSystems·2026
Same author

Tetrameric assembly disruption impairs CXCL4 chaperon ability for DNA and type I interferon immune amplification.

Communications biology·2026
Same author

Disease course, comorbidities, and treatment outcomes of lupus erythematosus panniculitis in adults and children: A retrospective review.

JAAD international·2026

Related Experiment Video

Updated: Sep 19, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.8K

Artificial intelligence-enabled precision medicine for inflammatory skin diseases.

Alice Tang1, Maria L Wei2,3, Anna Haemel2

  • 1Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA.

Arxiv
|June 4, 2025
PubMed
Summary

Artificial intelligence (AI) and machine learning are transforming dermatology, offering new ways to diagnose and treat inflammatory skin diseases. These technologies promise advancements in personalized medicine and clinical care for conditions like atopic dermatitis and psoriasis.

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.4K
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.9K

Related Experiment Videos

Last Updated: Sep 19, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.8K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.4K
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.9K

Area of Science:

  • Dermatology
  • Artificial Intelligence
  • Computational Biology

Background:

  • Dermatology is undergoing a transformation driven by artificial intelligence (AI) and advanced data collection.
  • Inflammatory skin diseases, including atopic dermatitis, psoriasis, hidradenitis suppurativa, and autoimmune connective tissue disease, are key areas for AI application.

Purpose of the Study:

  • To review the current applications of AI in inflammatory skin diseases.
  • To explore the potential of generative AI and machine learning in advancing dermatological research and care.
  • To discuss the integration of AI into clinical practice.

Main Methods:

  • Review of current literature on AI in dermatology.
  • Analysis of generative AI and machine learning methodologies.
  • Examination of AI's role in deep phenotyping, disease heterogeneity, drug development, personalized medicine, and clinical care.

Main Results:

  • AI and machine learning offer significant opportunities for enhanced diagnosis and treatment of inflammatory skin diseases.
  • These technologies can facilitate deep phenotyping and characterization of disease heterogeneity.
  • AI can accelerate drug development and enable personalized medicine approaches.

Conclusions:

  • AI and machine learning are poised to revolutionize inflammatory skin disease management.
  • Addressing the challenges and realizing the promises of AI is crucial for its successful integration into clinical practice.
  • A clear vision for AI integration is presented to advance dermatological care.